HEPATITIS C TREATMENTS EXPECTED TO CATAPULT GROUP PLAN DRUG SPENDING

Hepatitis C, an infectious and potentially fatal virus that harms the liver, is set to spur the largest drug spending growth in the country in more than a decade, a situation that could affect some health benefit plans, a group insurance seminar in Toronto was told in May.

Leave a Reply

Your email address will not be published. Required fields are marked *